[1]
M. H. NOOR, A. H. MUMTAZ, M. F. RAFIQ, H. ALI, A. RAHMAN, and M. A. HAIDER, “Open-Label Randomized Trial of High-Dose Rifampicin to Shorten Treatment for Drug-Sensitive Pulmonary TB (Hi-Dori-3)”, Annals Pak Med, vol. 1, no. 7, October, pp. 7–11, Oct. 2025.